Sjögren’s and non-Sjögren’s sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature

por Pucino, Valentina, Turner, Jason D, Nayar, Saba, Kollert, Florian, Rauz, Saaeha, Richards, Andrea, Higham, Jon, Poveda-Gallego, Ana, Bowman, Simon J, Barone, Francesca, Fisher, Benjamin A
Publicado 2022

Birmingham Behçet’s service: classification of disease and application of the 2014 International Criteria for Behçet’s Disease (ICBD) to a UK cohort

por Blake, Tim, Pickup, Luke, Carruthers, David, Damato, Erika Marie, Denniston, Alastair, Hamburger, John, Maxton, Claire, Mitton, Debbie, Murray, Philip I., Nightingale, Peter, Poveda-Gallego, Ana, Richards, Andrea, Whallett, Andrew, Situnayake, Deva
Publicado 2017

The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome

por Brown, Sarah, Navarro Coy, Nuria, Pitzalis, Costantino, Emery, Paul, Pavitt, Sue, Gray, Janine, Hulme, Claire, Hall, Frances, Busch, Robert, Smith, Pete, Dawson, Luke, Bombardieri, Michele, Wan-fai, Ng, Pease, Colin, Price, Elizabeth, Sutcliffe, Nurhan, Woods, Clodagh, Ruddock, Sharon, Everett, Colin, Reynolds, Catherine, Skinner, Emma, Poveda-Gallego, Ana, Rout, John, Macleod, Iain, Rauz, Saaeha, Bowman, Simon
Publicado 2014